Noah Goodman is Chief Business Officer of Kymera Therapeutics, Inc.. Currently has a direct ownership of 50,081 shares of KYMR, which is worth approximately $2.21 Million. The most recent transaction as insider was on Apr 08, 2025, when has been sold 50,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 50.1K
n/a 3M change
n/a 12M change
Total Value Held $2.21 Million

Noah Goodman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 08 2025
BUY
Grant, award, or other acquisition
-
50,000 Added 49.96%
50,081 Common Stock
NG

Noah Goodman

Chief Business Officer
Watertown, MA

Track Institutional and Insider Activities on KYMR

Follow Kymera Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KYMR shares.

Notify only if

Insider Trading

Get notified when an Kymera Therapeutics, Inc. insider buys or sells KYMR shares.

Notify only if

News

Receive news related to Kymera Therapeutics, Inc.

Track Activities on KYMR